AU

AUNA

AUNAHealthcareNASDAQ

Medical Care Facilities · Last scanned Oct 26, 2026

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$4.39B
-0.0% YoY
Net Income
$97.6M
-11.5% YoY
EBITDA
$856.7M
-3.4% YoY
Free Cash Flow
$315.0M

Scan Results

Daily timeframe
4 recent days hidden. Fresh signals are a Premium featureUpgrade →
DateIndicatorDetails
Oct 13CONFIRMED▲ Above MA150+0.6% from MA150, price crossed above
▲ MACD Positive CrossoverHistogram +0.0129, positive momentum
Oct 12CONFIRMED▲ Above MA200+0.4% from MA200, price crossed above
▼ Below MA1500.6% below MA150
▲ MACD Positive CrossoverHistogram +0.0065, positive momentum
About AUNA

AUNA operates in the Medical Care Facilities space. Auna S.A., a healthcare service provider, operates hospitals and clinics in Mexico, Peru, and Colombia. At a $382.1M market cap, AUNA ranks as a small-cap company within healthcare. The company provides prepaid healthcare; dental and vision insurance; and oncology plans.

Where AUNA stands vs its 150-day and 200-day moving averages

As of the October 13, 2026 close, AUNA finished 0.58% above its 150-day moving average ($5.15) and 1.57% above its 200-day moving average ($5.10). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.

Is AUNA overbought or oversold?

At the October 13, 2026 close, AUNA's RSI(14) was 47.1, in neutral territory (between 30 and 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.

Key stats
Market Cap$382.1M
P/E (TTM)86.00
Fwd P/E4.76
EPS$0.06
Beta0.62
52W Change-14.4%
Dividend Yield0.00%
ROE1.6%
Analysis

On the balance sheet, AUNA has $481.3M in cash with $3.80B in obligations. The ability to service this debt comfortably depends on continued operational cash generation. Free cash flow comes in at $315.0M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. Return on equity stands at 1.6%, which is modest for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. An ROA of 5.2% suggests reasonable efficiency in deploying the company's asset base. Revenue has grown from $2.45B (2022) to $4.39B (2025), reflecting a 79% increase over the period.

With a beta below 0.7, AUNA typically sees smaller price swings than the overall market, offering a degree of stability during turbulent periods. AUNA carries a heavier debt load relative to its cash position, which introduces financial risk that investors should weigh. At over 50x earnings, AUNA carries valuation risk — any slowdown in growth expectations could lead to meaningful price adjustments. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence AUNA's trajectory.

Links
More Healthcare stocks
Browse all stocks →
⚠Not financial advice. Scanance shows end-of-day technical indicators (not real-time prices) for information only. Results can be wrong; past performance does not guarantee future results.PrivacyTerms